Reset
Showing 20 of 72 academic articles

How to promote repurchase intention toward Covid-19 antigen test kits: Evidence from Thai consumers

Long Kim, Thanapa Chouykaew, Siwarit Pongsakornrungsilp, Teerasak Jindabot et al. • Innovative Marketing (2023)

Promoting repurchase intention to existing consumers is a crucial advantage that helps businesses manage sufficient supply for their customers and ensure their business sustainability. Business managers must understand factors that can sign...

DOAJ Open Access (DOAJ) DOI: 10.21511/im.19(1).2023.16

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

Katie S. Gatwood, Bhagirathbhai R. Dholaria, Mariana Lucena, Brittney Baer et al. • eJHaem (2022)

Abstract Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T‐cell therapy (CART), have demonstrated...

DOAJ Open Access (DOAJ) DOI: 10.1002/jha2.333

Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer

Sophia Daum, Lilith Decristoforo, Mira Mousa, Stefan Salcher et al. • Molecular Cancer (2025)

Abstract The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit diverse immunomodu...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12943-024-02221-6

Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors

Kuniyasu Niizuma, Yoshikazu Ogawa, Takayuki Kogure, Teiji Tominaga • BMC Infectious Diseases (2020)

Abstract Background Hepatitis B virus (HBV) infection is a major public health problem worldwide. More than 2 billion people have been exposed to HBV, and about 257 million individuals are chronic carriers of HBV. HBV reactivation has been ...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12879-020-04971-2

A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma

Tan Zhang, Tan Zhang, Sina Zhang, Sina Zhang et al. • Frontiers in Cellular and Infection Microbiology (2021)

Cholangiocarcinoma (CCA) is a malignant hepatic tumor with a poor prognosis, which needs early diagnosis urgently. The gut microbiota has been shown to play a crucial role in the progression of liver cancer. Here, we explored a gut microbio...

DOAJ Open Access (DOAJ) DOI: 10.3389/fcimb.2021.751795

Seroprevalence and risk factors of porcine cysticercosis in Mpwapwa district, eastern-Central Tanzania

Justine Daudi Maganira, Noel Mark Makwinya, Beda John Mwang'onde • Parasite Epidemiology and Control (2025)

Porcine cysticercosis, caused by the larval stage of Taenia species, poses significant health and economic challenges in low and lower-middle-income regions. This study assessed the seroprevalence and risk factors associated with the transm...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.parepi.2025.e00445

Low Pathogenic Avian Influenza H9N2 Viruses in Morocco: Antigenic and Molecular Evolution from 2021 to 2023

Oumayma Arbani, Mariette F. Ducatez, Salma Mahmoudi, Faiçal Salamat et al. • Viruses (2023)

Avian influenza viruses pose significant threats to both the poultry industry and public health worldwide. Among them, the H9N2 subtype has gained substantial attention due to its high prevalence, especially in Asia, the Middle East, and Af...

DOAJ Open Access (DOAJ) DOI: 10.3390/v15122355

MOLECULAR BIOLOGY OF MYCOPLASMAS

Kevin F. Dybvig, LeRoy L. Voelker • Annual Review of Microbiology (1996)

Although mycoplasmas lack cell walls, they are in many respects similar to the gram-positive bacteria with which they share a common ancestor. The molecular biology of mycoplasmas is intriguing because the chromosome is uniquely small (< 60...

OPENALEX DOI: https://doi.org/10.1146/annurev.micro.50.1.25

Genotypic Variants of Pandemic H1N1 Influenza A Viruses Isolated from Severe Acute Respiratory Infections in Ukraine during the 2015/16 Influenza Season

Oksana Zolotarova, Anna Fesenko, Olga Holubka, Larysa Radchenko et al. • Viruses (2021)

Human type A influenza viruses A(H1N1)pdm09 have caused seasonal epidemics of influenza since the 2009–2010 pandemic. A(H1N1)pdm09 viruses had a leading role in the severe epidemic season of 2015/16 in the Northern Hemisphere and caused a h...

DOAJ Open Access (DOAJ) DOI: 10.3390/v13112125

Goldenhar syndrome: a cause of secondary immunodeficiency?

De Golovine Serge, Wu Shuya, Hunter Jill V, Shearer William T • Allergy, Asthma & Clinical Immunology (2012)

Abstract Goldenhar syndrome (GS) results from an aberrant development of the 1st and 2nd branchial arches. There is a wide range of clinical manifestations, the most common being microtia, hemifacial microsomia, epibulbar dermoids and verte...

DOAJ Open Access (DOAJ) DOI: 10.1186/1710-1492-8-10

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology (2025)

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2024.1489827

Lung cancer tumor immune microenvironment: analyzing immune escape mechanisms and exploring emerging therapeutic targets

Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology (2025)

Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2025.1597686

Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CARNK cells

Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development (2024)

Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.omtm.2024.101328

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration

Christoph M. Janitzek, Philip H. R. Carlsen, Susan Thrane, Vijansh M. Khanna et al. • Vaccines (2021)

Capsid-like particle (CLP) displays can be used to enhance the immunogenicity of vaccine antigens, but a better understanding of how CLP vaccines are best formulated and delivered is needed. This study compared the humoral immune responses ...

DOAJ Open Access (DOAJ) DOI: 10.3390/vaccines9020131

Characterization of Primate Antibody Responses to Administered Murine Monoclonal Immunoglobulin

D.E. Milenic, B. Detrick, J.C. Reynolds, D. Colcher • The International Journal of Biological Markers (1990)

Murine monoclonal antibodies (MAb) are currently being assessed for their utility as tools in cancer management. Anti-murine immunoglobulin responses have been observed in many patients receiving monoclonal antibody treatment. In this study...

DOAJ Open Access (DOAJ) DOI: 10.1177/172460089000500403

Immunology for physicists

Alan S. Perelson, Gérard Weisbuch • Reviews of Modern Physics (1997)

The immune system is a complex system of cells and molecules that can provide us with a basic defense against pathogenic organisms. Like the nervous system, the immune system performs pattern recognition tasks, learns, and retains a memory ...

OPENALEX DOI: https://doi.org/10.1103/revmodphys.69.1219

Cancer Immunology

Olivera J. Finn • New England Journal of Medicine (2008)

This review is a comprehensive account of the current status of tumor immunology, beginning with the identification of human tumor antigens and ending with a summary of clinical applications of what we know about the immunology of tumors....

OPENALEX DOI: https://doi.org/10.1056/nejmra072739